Cystic fibrosis and survival to 40 years: a case-control study
- PMID: 20378603
- DOI: 10.1183/09031936.00001710
Cystic fibrosis and survival to 40 years: a case-control study
Abstract
The clinical course of patients with cystic fibrosis (CF) is variable and probably determined by many interacting factors. We aimed to examine the influence of early social and clinical factors on long-term survival. A case-control study of adult CF patients was used to compare long-term survivors (aged ≥ 40 yrs) with patients who died before reaching 30 yrs of age. Each case (n = 78) was matched by birth date with at least one control (n = 152), after exclusion of "late diagnosis" patients. Probability-weighted logistic regression models were used to identify influences on survival. Factors resulting in increased probabilities of survival included high body mass index (OR 1.76, 95% CI 1.40-2.22), forced expiratory volume in 1 s (OR per 5% increase 1.54, 95% CI 1.32-1.80), and forced vital capacity (OR per 5% increase 1.54, 95% CI 1.33-1.78) at transfer to the adult clinic and the exclusive use of oral antibiotics (OR 8.31, 95% CI 3.02-22.88). Factors resulting in decreased probabilities of survival were Pseudomonas aeruginosa acquisition (OR 0.18, 95% 0.05-0.65) or pneumothorax before transfer to the adult clinic (OR 0.02, 95% CI 0.004-0.08) and referral from a paediatric clinic in a deprived area (OR 0.13, 95% CI 0.04-0.38). Long-term survival is associated with the clinical features present by the time of referral to an adult clinic. Even "early-diagnosis" disease appears to have different phenotypes, possibly independent of CF gene function, that have different survival patterns.
Similar articles
-
Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort study.Pediatr Pulmonol. 2010 Jun;45(6):601-7. doi: 10.1002/ppul.21227. Pediatr Pulmonol. 2010. PMID: 20503286
-
Late diagnosis defines a unique population of long-term survivors of cystic fibrosis.Am J Respir Crit Care Med. 2005 Mar 15;171(6):621-6. doi: 10.1164/rccm.200403-404OC. Epub 2004 Dec 10. Am J Respir Crit Care Med. 2005. PMID: 15591474
-
Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane conductance regulator function.Eur Respir J. 2011 May;37(5):1076-82. doi: 10.1183/09031936.00079010. Epub 2010 Sep 16. Eur Respir J. 2011. PMID: 20847077
-
Pathophysiology and management of pulmonary infections in cystic fibrosis.Am J Respir Crit Care Med. 2003 Oct 15;168(8):918-51. doi: 10.1164/rccm.200304-505SO. Am J Respir Crit Care Med. 2003. PMID: 14555458 Review.
-
Common clinical features of CF (respiratory disease and exocrine pancreatic insufficiency).Presse Med. 2017 Jun;46(6 Pt 2):e109-e124. doi: 10.1016/j.lpm.2017.03.021. Epub 2017 May 26. Presse Med. 2017. PMID: 28554722 Review.
Cited by
-
Managing the underlying cause of cystic fibrosis: a future role for potentiators and correctors.Paediatr Drugs. 2013 Oct;15(5):393-402. doi: 10.1007/s40272-013-0035-3. Paediatr Drugs. 2013. PMID: 23757197 Review.
-
Evaluating outpatient transition clinics: a mixed-methods study protocol.BMJ Open. 2016 Aug 26;6(8):e011926. doi: 10.1136/bmjopen-2016-011926. BMJ Open. 2016. PMID: 27566639 Free PMC article.
-
Association between the IVS4G>T mutation in the TCF7L2 gene and susceptibility to diabetes in cystic fibrosis patients.BMC Res Notes. 2012 Oct 10;5:561. doi: 10.1186/1756-0500-5-561. BMC Res Notes. 2012. PMID: 23050589 Free PMC article.
-
Treatment of pulmonary exacerbations in cystic fibrosis.Eur Respir Rev. 2013 Sep 1;22(129):205-16. doi: 10.1183/09059180.00006512. Eur Respir Rev. 2013. PMID: 23997047 Free PMC article. Review.
-
Pneumothorax in cystic fibrosis.J Thorac Dis. 2014 Oct;6(Suppl 4):S480-7. doi: 10.3978/j.issn.2072-1439.2014.09.27. J Thorac Dis. 2014. PMID: 25337406 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical